Baxter R - Search Results

1

Safety of Zostavax™--a cohort study in a managed care organization.

Baxter R, Tran TN, Hansen J, Emery M, Fireman B, Bartlett J, Lewis N, Saddier P. Baxter R, et al. Vaccine. 2012 Oct 19;30(47):6636-41. doi: 10.1016/j.vaccine.2012.08.070. Epub 2012 Sep 8. Vaccine. 2012. PMID: 22963800

2

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.

Hansen J, Zhang L, Klein NP, Robertson CA, Decker MD, Greenberg DP, Bassily E, Baxter R. Hansen J, et al. Among authors: baxter r. Vaccine. 2017 Dec 14;35(49 Pt B):6879-6884. doi: 10.1016/j.vaccine.2017.09.032. Epub 2017 Sep 21. Vaccine. 2017. PMID: 28941623 Free article. Clinical Trial.

3

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children.

Hansen J, Zhang L, Eaton A, Baxter R, Robertson CA, Decker MD, Greenberg DP, Bassily E, Klein NP. Hansen J, et al. Among authors: baxter r. Vaccine. 2018 Apr 12;36(16):2133-2138. doi: 10.1016/j.vaccine.2018.02.107. Epub 2018 Mar 14. Vaccine. 2018. PMID: 29550195 Free article.

4

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study.

Baxter RP, Lewis N, Fireman B, Hansen J, Klein NP, Ortiz JR. Baxter RP, et al. Pediatr Infect Dis J. 2018 May;37(5):383-386. doi: 10.1097/INF.0000000000001783. Pediatr Infect Dis J. 2018. PMID: 28914750 Free PMC article. Clinical Trial.

5

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies.

Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, Black S, Galindo C, Schmidt J, Baxter R. Klein NP, et al. Among authors: baxter r. Vaccine. 2010 Jan 22;28(4):1062-8. doi: 10.1016/j.vaccine.2009.10.115. Epub 2009 Nov 5. Vaccine. 2010. PMID: 19896453

6

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.

Baxter R, Ray GT, Fireman BH. Baxter R, et al. Vaccine. 2010 Oct 21;28(45):7267-72. doi: 10.1016/j.vaccine.2010.08.088. Epub 2010 Sep 9. Vaccine. 2010. PMID: 20832494

7

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.

Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. Baxter R, et al. Vaccine. 2012 Apr 19;30(19):2989-98. doi: 10.1016/j.vaccine.2012.02.039. Epub 2012 Feb 29. Vaccine. 2012. PMID: 22386746 Free article.

8

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.

Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. Baxter R, et al. Vaccine. 2012 Apr 26;30(20):3053-60. doi: 10.1016/j.vaccine.2012.02.080. Epub 2012 Mar 13. Vaccine. 2012. PMID: 22425787 Free article.

9

Biologically plausible and evidence-based risk intervals in immunization safety research.

Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Rowhani-Rahbar A, et al. Among authors: baxter r. Vaccine. 2012 Dec 17;31(1):271-7. doi: 10.1016/j.vaccine.2012.07.024. Epub 2012 Jul 24. Vaccine. 2012. PMID: 22835735 Review.

10

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.

Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, Lewis E, Fireman B, Saddier P. Baxter R, et al. Pediatrics. 2013 May;131(5):e1389-96. doi: 10.1542/peds.2012-3303. Epub 2013 Apr 1. Pediatrics. 2013. PMID: 23545380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters